VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+33.1%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$103M
AUM Growth
+$103M
(+15%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 71.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
| $33M | 32.13% | 1,806,832 | – | – |
|
2
Ocular Therapeutix
OCUL
$2.12B
| $18.5M | 18.05% | 2,215,384 | – | – |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $18.1M | 17.61% | 407,416 | – | – |
|
|
AKAO
4
DELISTED
Achaogen, Inc.
AKAO
| $16.7M | 16.24% | 1,281,152 | – | – |
|
|
IMDZ
5
DELISTED
Immune Design Corp.
IMDZ
| $12.1M | 11.82% | 2,208,210 | – | – |
|
6
Glaukos
GKOS
$5.5B
| $2.45M | 2.38% | 71,428 | – | – |
|
|
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
| $1.81M | 1.77% | 1,048,601 | – | – |
|